Arcturus Therapeutics Holdings (ARCT) Gains from Investment Securities (2018 - 2024)
Historic Gains from Investment Securities for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q4 2024 value amounting to $564000.0.
- Arcturus Therapeutics Holdings' Gains from Investment Securities fell 8825.49% to $564000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $3.3 million, marking a year-over-year decrease of 2325.58%. This contributed to the annual value of $8.1 million for FY2024, which is 135.02% up from last year.
- Arcturus Therapeutics Holdings' Gains from Investment Securities amounted to $564000.0 in Q4 2024, which was down 8825.49% from $2.7 million recorded in Q1 2024.
- Over the past 5 years, Arcturus Therapeutics Holdings' Gains from Investment Securities peaked at $30.7 million during Q2 2022, and registered a low of -$4.3 million during Q3 2021.
- Moreover, its 5-year median value for Gains from Investment Securities was $1.3 million (2020), whereas its average is $5.1 million.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 15308.64% in 2021, then soared by 64501.99% in 2024.
- Over the past 5 years, Arcturus Therapeutics Holdings' Gains from Investment Securities (Quarter) stood at $21.2 million in 2020, then tumbled by 71.37% to $6.1 million in 2021, then skyrocketed by 405.79% to $30.7 million in 2022, then tumbled by 84.38% to $4.8 million in 2023, then crashed by 88.25% to $564000.0 in 2024.
- Its Gains from Investment Securities was $564000.0 in Q4 2024, compared to $2.7 million in Q1 2024 and $4.8 million in Q4 2023.